ERBB2 and breast carcinoma: These include enhanced expression of HER2 proteins (Fig. 2a) and strong cis-phosphorylation (Fig. 2b) in HER2-positive breast cancers, cementing their role as potent drivers of alterations in a subset of breast cancers.